Postpartum screening of women with GDM in specialised practices: Data from 12,991 women in the GestDiab register
Ute Linnenkamp, Gregory Gordon Greiner, Burkhard Haastert, Heinke Adamczewski, Matthias Kaltheuner, Dietmar Weber, Andrea Icks
Abstract
Abstract Background Gestational diabetes (GDM) in the short term is associated with various complications during pregnancy; however, in the long run, women have an increased risk of type 2 diabetes mellitus (T2DM). Therefore, short‐ and long‐term follow‐up postpartum is recommended. Methods We assessed the proportion of postpartum diabetes screening among 12,991 women with their first GDM‐diagnosed pregnancy in the study period in the nationwide German GestDiab register between 2015 and 2017. In addition to assessing prevalence, we assessed if the probability of postpartum screening was associated with maternal characteristics or pregnancy outcomes. Results In total, 38.2% (95% CI 32.8%–43.7%) of our sample underwent postpartum diabetes screening, irrespective of its timing. Around 50% of women (19.3% of the total sample) undertook the screening in the recommended time frame of 6–12 weeks postpartum. We found that age, native language, pre‐pregnancy BMI, smoking status, number of previous pregnancies, fasting plasma glucose and HbA 1c levels as well as previous pregnancies with GDM and treatment with insulin were associated with participation in the postpartum diabetes screening in our sample. Conclusion In our study, more than 60% of the women with GDM did not participate in postpartum diabetes screening. This is a missed opportunity in a high‐risk population to detect glucose intolerance. Consequently, appropriate interventions to prevent the progression to T2DM cannot be initiated. Further research should investigate barriers and enabling factors and allow developing a multilevel approach for GDM postpartum care.